From The BBC:
The new chief executive of pharmaceutical giant GlaxoSmithKline had said the company will cut prices for its drugs in the developing world.
Andrew Witty said GSK would cut the cost of drugs in the 50 poorest nations to 25% of price in the UK and US.
He also said the firm would share knowledge of patents and reinvest profits in local clinics.
Charities have long campaigned for such a policy as patents prevent cheaper generic versions of drugs.
Mr Witty told the Guardian newspaper drugs companies had a duty to help the poor.
He said: “We work like crazy to come up with the next great medicine, knowing that it’s likely to get used an awful lot in developed countries, but we could do something for developing countries.
“Are we working as hard on that? I want to be able to say yes we are, and that’s what this is all about – trying to make sure we are even-handed in terms of our efforts to find solutions not just for developed but for developing countries.”…